These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 36941622)
21. Association of serum KL-6 levels with interstitial lung disease in patients with connective tissue disease: a cross-sectional study. Oguz EO; Kucuksahin O; Turgay M; Yildizgoren MT; Ates A; Demir N; Kumbasar OO; Kinikli G; Duzgun N Clin Rheumatol; 2016 Mar; 35(3):663-6. PubMed ID: 26758437 [TBL] [Abstract][Full Text] [Related]
22. Factors for progressive pulmonary fibrosis in connective tissue disease-related interstitial lung disease. Kim K; Lee J; Jo YS Ther Adv Respir Dis; 2023; 17():17534666231212301. PubMed ID: 37991015 [TBL] [Abstract][Full Text] [Related]
23. Comparison of characteristics of connective tissue disease-associated interstitial lung diseases, undifferentiated connective tissue disease-associated interstitial lung diseases, and idiopathic pulmonary fibrosis in Chinese Han population: a retrospective study. Pan L; Liu Y; Sun R; Fan M; Shi G Clin Dev Immunol; 2013; 2013():121578. PubMed ID: 24171031 [TBL] [Abstract][Full Text] [Related]
24. Association of Red Blood Cell Distribution Width Levels with Connective Tissue Disease-Associated Interstitial Lung Disease (CTD-ILD). Shi S; Chen L; Gui X; Chen L; Qiu X; Yu M; Xiao Y Dis Markers; 2021; 2021():5536360. PubMed ID: 34457089 [TBL] [Abstract][Full Text] [Related]
25. Management of interstitial lung disease associated with connective tissue disease. Mathai SC; Danoff SK BMJ; 2016 Feb; 352():h6819. PubMed ID: 26912511 [TBL] [Abstract][Full Text] [Related]
26. Rituximab versus cyclophosphamide for the treatment of connective tissue disease-associated interstitial lung disease (RECITAL): study protocol for a randomised controlled trial. Saunders P; Tsipouri V; Keir GJ; Ashby D; Flather MD; Parfrey H; Babalis D; Renzoni EA; Denton CP; Wells AU; Maher TM Trials; 2017 Jun; 18(1):275. PubMed ID: 28619061 [TBL] [Abstract][Full Text] [Related]
27. The value of serum Krebs von den lungen-6 as a diagnostic marker in connective tissue disease associated with interstitial lung disease. Ma H; Lu J; Song Y; Wang H; Yin S BMC Pulm Med; 2020 Jan; 20(1):6. PubMed ID: 31915006 [TBL] [Abstract][Full Text] [Related]
28. Treatment of pulmonary hypertension in patients with connective tissue disease and interstitial lung disease. Mittoo S; Jacob T; Craig A; Bshouty Z Can Respir J; 2010; 17(6):282-6. PubMed ID: 21165350 [TBL] [Abstract][Full Text] [Related]
32. Prevalence of diaphragm dysfunction in patients with interstitial lung disease (ILD): The role of diaphragmatic ultrasound. Bernardinello N; Cocconcelli E; Boscolo A; Castelli G; Sella N; Giraudo C; Zanatta E; Rea F; Saetta M; Navalesi P; Spagnolo P; Balestro E Respir Med; 2023 Sep; 216():107293. PubMed ID: 37271302 [TBL] [Abstract][Full Text] [Related]
33. Prediction of long-term mortality by using machine learning models in Chinese patients with connective tissue disease-associated interstitial lung disease. Sun D; Wang Y; Liu Q; Wang T; Li P; Jiang T; Dai L; Jia L; Zhao W; Cheng Z Respir Res; 2022 Jan; 23(1):4. PubMed ID: 34996461 [TBL] [Abstract][Full Text] [Related]
34. Acute exacerbations of fibrosing interstitial lung disease associated with connective tissue diseases: a population-based study. Cao M; Sheng J; Qiu X; Wang D; Wang D; Wang Y; Xiao Y; Cai H BMC Pulm Med; 2019 Nov; 19(1):215. PubMed ID: 31727051 [TBL] [Abstract][Full Text] [Related]
35. Multidimensional improvement in connective tissue disease-associated interstitial lung disease: Two courses of pulse dose methylprednisolone followed by low-dose prednisone and tacrolimus. Yamano Y; Taniguchi H; Kondoh Y; Ando M; Kataoka K; Furukawa T; Johkoh T; Fukuoka J; Sakamoto K; Hasegawa Y Respirology; 2018 Nov; 23(11):1041-1048. PubMed ID: 30011421 [TBL] [Abstract][Full Text] [Related]
36. IPAF should receive early treatment for sharing similar clinical characteristics as CTD-ILD: a report from 273 Chinese patients. Li Y; Zheng Z; Han Q; Li Z; Xie R; Zhang R; Zhang B; Zhu P Clin Rheumatol; 2020 Dec; 39(12):3817-3823. PubMed ID: 32447599 [TBL] [Abstract][Full Text] [Related]
37. Serum Rcn3 level is a potential diagnostic biomarker for connective tissue disease-associated interstitial lung disease and reflects the severity of pulmonary function. Ding F; Yang L; Wang Y; Wang J; Ma Y; Jin J BMC Pulm Med; 2023 Feb; 23(1):68. PubMed ID: 36800954 [TBL] [Abstract][Full Text] [Related]
38. KL-6 levels in the connective tissue disease population: typical values and potential confounders-a retrospective, real-world study. Zhou A; Tang H; Peng W; Wang Y; Tang X; Yang H; Lu R; Pan P Front Immunol; 2023; 14():1098602. PubMed ID: 37409133 [TBL] [Abstract][Full Text] [Related]
39. [Characteristics and clinical significance of pulmonary function test and KL-6 in ASSD-ILD and IPF]. Sun D; Cheng Z; Jiang TC; Li PF; Jia LQ; Wang TT; Zheng CP; Li Y; Duo MJ Zhonghua Yi Xue Za Zhi; 2020 Mar; 100(10):748-752. PubMed ID: 32192286 [No Abstract] [Full Text] [Related]
40. The correlation between miR-200c and the severity of interstitial lung disease associated with different connective tissue diseases. Jiang Z; Tao JH; Zuo T; Li XM; Wang GS; Fang X; Xu XL; Li XP Scand J Rheumatol; 2017 Mar; 46(2):122-129. PubMed ID: 27309544 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]